| __timestamp | PTC Therapeutics, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 79838000 | 94103000 |
| Thursday, January 1, 2015 | 121816000 | 146194000 |
| Friday, January 1, 2016 | 117633000 | 130000 |
| Sunday, January 1, 2017 | 4577000 | 7353000 |
| Monday, January 1, 2018 | 12670000 | 34193000 |
| Tuesday, January 1, 2019 | 12135000 | 56586000 |
| Wednesday, January 1, 2020 | 18942000 | 63382000 |
| Friday, January 1, 2021 | 32328000 | 97049000 |
| Saturday, January 1, 2022 | 44678000 | 139989000 |
| Sunday, January 1, 2023 | 65486000 | 150343000 |
In pursuit of knowledge
In the competitive landscape of biotechnology, understanding cost structures is pivotal. This analysis delves into the annual cost of revenue for two prominent players: Sarepta Therapeutics, Inc. and PTC Therapeutics, Inc. Over the past decade, Sarepta has consistently outpaced PTC in cost of revenue, peaking in 2023 with a 15% increase from the previous year. In contrast, PTC's costs have shown a more volatile trend, with a notable 43% rise from 2020 to 2023.
This data underscores the importance of strategic financial management in sustaining growth and competitiveness in the biotech sector.
Cost of Revenue Trends: Novo Nordisk A/S vs Sarepta Therapeutics, Inc.
Cost of Revenue Trends: Sanofi vs PTC Therapeutics, Inc.
Cost of Revenue: Key Insights for Bristol-Myers Squibb Company and PTC Therapeutics, Inc.
Analyzing Cost of Revenue: Gilead Sciences, Inc. and Sarepta Therapeutics, Inc.
Cost Insights: Breaking Down Takeda Pharmaceutical Company Limited and Sarepta Therapeutics, Inc.'s Expenses
BeiGene, Ltd. vs Sarepta Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue Trends: Viatris Inc. vs PTC Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: BioMarin Pharmaceutical Inc. vs PTC Therapeutics, Inc.
Analyzing Cost of Revenue: Sarepta Therapeutics, Inc. and Grifols, S.A.
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Perrigo Company plc's Expenses
Cost Insights: Breaking Down Sarepta Therapeutics, Inc. and Galapagos NV's Expenses
PTC Therapeutics, Inc. vs Galapagos NV: Efficiency in Cost of Revenue Explored